Interestingly, in a preclinical study using sgRNA library screening and knockout tumor xenograft models, only the loss-of-function mutation of KEAP1 (but not STK11/LKB1) induced partial resistance to adagrasib [54]. Here, STK11 is linked to neoplasm.